These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 3057327)
1. Vancomycin ototoxicity and nephrotoxicity. A review. Bailie GR; Neal D Med Toxicol Adverse Drug Exp; 1988; 3(5):376-86. PubMed ID: 3057327 [TBL] [Abstract][Full Text] [Related]
2. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Elting LS; Rubenstein EB; Kurtin D; Rolston KV; Fangtang J; Martin CG; Raad II; Whimbey EE; Manzullo E; Bodey GP Cancer; 1998 Dec; 83(12):2597-607. PubMed ID: 9874468 [TBL] [Abstract][Full Text] [Related]
3. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340 [TBL] [Abstract][Full Text] [Related]
5. [Glycopeptides and the newborn infant's kidney]. Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651 [TBL] [Abstract][Full Text] [Related]
6. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Matson KL; Shaffer CL; Beck GL; Simonsen KA Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622 [TBL] [Abstract][Full Text] [Related]
8. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis. Horey A; Mergenhagen KA; Mattappallil A Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306 [TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity. Rostas SE; Kubiak DW; Calderwood MS Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573 [TBL] [Abstract][Full Text] [Related]
10. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy. Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556 [TBL] [Abstract][Full Text] [Related]
11. Ototoxicity and Nephrotoxicity With Elevated Serum Concentrations Following Vancomycin Overdose: A Retrospective Case Series. Uda K; Suwa J; Ito K; Hataya H; Horikoshi Y J Pediatr Pharmacol Ther; 2019; 24(5):450-455. PubMed ID: 31598110 [TBL] [Abstract][Full Text] [Related]
12. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Cimino MA; Rotstein C; Slaughter RL; Emrich LJ Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577 [TBL] [Abstract][Full Text] [Related]
13. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients? Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842 [TBL] [Abstract][Full Text] [Related]
15. Ototoxic and nephrotoxic drugs in neonatal intensive care units: results of a Spanish and Italian survey. Arribas C; Decembrino N; Raffaeli G; Amodeo I; González-Caballero JL; Riaza M; Ortiz-Movilla R; Massenzi L; Gizzi C; Araimo G; Cattarelli D; Aversa S; Martinelli S; Frezza S; Orfeo L; Mosca F; Cavallaro G; Garrido F; Eur J Pediatr; 2024 Jun; 183(6):2625-2636. PubMed ID: 38492032 [TBL] [Abstract][Full Text] [Related]
16. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Nahata MC Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631 [TBL] [Abstract][Full Text] [Related]
17. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity. Darko W; Medicis JJ; Smith A; Guharoy R; Lehmann DE Pharmacotherapy; 2003 May; 23(5):643-50. PubMed ID: 12741439 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Burgess LD; Drew RH Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041 [TBL] [Abstract][Full Text] [Related]
19. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH; Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995 [TBL] [Abstract][Full Text] [Related]
20. Long-term vancomycin use had low risk of ototoxicity. Humphrey C; Veve MP; Walker B; Shorman MA PLoS One; 2019; 14(11):e0224561. PubMed ID: 31693679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]